Amit Kumar, Robert Berman, Mike Catelani

Amit Kumar was named president and CEO of Itus, which is developing blood-based solid tumor cancer diagnostics. He replaces Robert Berman, who resigned as president, CEO, and as a director. Kumar, formerly CEO of CombiMatrix, has been the executive chairman of Itus for the past year, and has been a director since joining the firm in 2012. Also, Mike Catelani, Itus' CFO, has been promoted to chief operating officer.